4.8 Article

Th2-TRMs Maintain Life-Long Allergic Memory in Experimental Asthma in Mice

Journal

FRONTIERS IN IMMUNOLOGY
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2019.00840

Keywords

T-RMs; Th2 cells; asthma; allergy; mice

Categories

Funding

  1. Public Private Partnership for Asthma Imaging and Genomics (P3AGI) FP7 Project [230739]
  2. Hochschuljubilaeumsstiftung der StadtWien [H-314145/2017]

Ask authors/readers for more resources

Allergic asthma is a chronic inflammatory remitting-relapsing disease affecting the airways. Long-lived allergen-specific memory CD4(+) T helper 2 (Th2) cells in mice persist in lungs for more than 2 years after the induction of experimental allergic asthma (EAA). To further understand lung Th2 memory cells, we tracked CD4+ T cells in spleen and lungs from healthy mice, through the initiation of acute EAA, recovery (remission), and allergen-induced disease relapse. We identified a lung CD3(+) CD4(+) cell subset that expresses CD44(hi)CD62L(-)CD69(+)ST2(+), produces Th2 cytokines, and mediates allergen-induced disease relapse despite treatment with FTY720 and anti-CD4 antibody. These cells reside in the lung tissue for the lifetime of mice (>665 days) and represent long-lived pathogenic Th2 tissue resident memory cells (T-RMs) that maintain allergic memory in lung. We speculate that these data implicate that human Th2-T-RMs sentinels in lungs of patients are poised to rapidly respond to inhaled allergen and induce asthma attacks and that therapeutic approaches targeting these cells may provide relief to patients with allergic asthma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Immunology

Imaging dendritic cell functions

Berislav Bosnjak, Kim Thi Hoang Do, Reinhold Foerster, Swantje Hammerschmidt

Summary: Dendritic cells (DCs) play a crucial role in initiating adaptive immune responses by capturing antigens during inflammation and inducing tolerance under non-inflammatory conditions. Understanding DC biology is essential for vaccine development and autoimmune disease prevention. Bioimaging tools are crucial for tracking DCs in tissues and organs and visualizing subcellular and molecular processes.

IMMUNOLOGICAL REVIEWS (2022)

Review Biochemistry & Molecular Biology

Challenges of CRISPR-Based Gene Editing in Primary T Cells

Alaleh Rezalotfi, Lea Fritz, Reinhold Foerster, Berislav Bosnjak

Summary: Adaptive T-cell immunotherapy shows great promise for leukemia and chronic virus infections in immunosuppressed patients. Genetic modification using CRISPR/Cas system simplifies the production of immunotherapy cells and allows for genome-specific gene insertion or deletion. This review discusses recent methodological breakthroughs, important considerations, and potential pitfalls in conducting these genetic modifications.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Unprecedented Epimerization of an Azithromycin Analogue: Synthesis, Structure and Biological Activity of 2′-Dehydroxy-5-Epi-Azithromycin

Goran Kragol, Victoria A. Steadman, Zorica Marusic Istuk, Ana Cikos, Martina Bosnar, Dubravko Jelic, Gabrijela Ergovic, Marija Trzun, Berislav Bosnjak, Ana Bokulic, Jasna Padovan, Ines Glojnaric, Vesna Erakovic Haber

Summary: This study reveals a novel azithromycin analog with good anti-inflammatory properties obtained via Barton-McCombie oxidation, which has the potential to treat chronic inflammatory diseases.

MOLECULES (2022)

Article Food Science & Technology

Scientific Opinion on development needs for the allergenicity and protein safety assessment of food and feed products derived from biotechnology

Ewen Mullins, Jean-Louis Bresson, Tamas Dalmay, Ian Crawford Dewhurst, Michelle M. Epstein, Leslie George Firbank, Philippe Guerche, Jan Hejatko, Hanspeter Naegeli, Fabien Nogue, Nils Rostoks, Jose Juan Sanchez Serrano, Giovanni Savoini, Eve Veromann, Fabio Veronesi, Antonio Fernandez Dumont, Francisco Javier Moreno

Summary: This article discusses the formulation of specific development needs for allergenicity assessment and protein safety, emphasizing the importance of updating and modernizing current risk assessment strategies. It highlights the need to consider clinical relevance, exposure routes, and potential threshold values of food allergens in the assessment process. The article also recognizes that more complex products in the future will require a reevaluation of existing guidelines and the clarification of the purpose of allergenicity risk assessment.

EFSA JOURNAL (2022)

Article Food Science & Technology

Proteomic Profiling of Major Peanut Allergens and Their Post-Translational Modifications Affected by Roasting

Teodora Dukic, Katarina Smiljanic, Jelena Mihailovic, Ivana Prodic, Danijela Apostolovic, Shu-Hua Liu, Michelle M. Epstein, Marianne van Hage, Dragana Stanic-Vucinic, Tanja Cirkovic Velickovic

Summary: This study investigates the impact of peanut roasting on the post-translational modification (PTM) profiles of major peanut allergens. It finds that roasting can induce changes in certain PTMs, and Ara h 1 is the most modified major allergen in both raw and roasted samples.

FOODS (2022)

Article Food Science & Technology

Assessment of genetically modified oilseed rape GT73 for placing on the market of isolated seed protein for food under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-026/2)

Ewen Mullins, Jean-Louis Bresson, Tamas Dalmay, Ian Crawford Dewhurst, Michelle M. Epstein, Leslie George Firbank, Philippe Guerche, Jan Hejatko, Francisco Javier Moreno, Hanspeter Naegeli, Fabien Nogue, Nils Rostoks, Jose Juan Sanchez Serrano, Giovanni Savoini, Eve Veromann, Fabio Veronesi, Antonio Fernandez, Andrea Gennaro, Jose Angel Gomez Ruiz, Paolo Lenzi, Ana Martin Camargo, Aleksandra Lewandowska, Pietro Piffanelli, Tommaso Raffaello

Summary: The genetically modified oilseed rape GT73 has been assessed for its safety in terms of food, human and animal health, and environment. The assessment concluded that there are no biologically relevant differences in compositional, agronomic and phenotypic characteristics compared to the conventional counterpart, except for the newly expressed proteins. The presence of these proteins does not raise safety concerns. Therefore, the consumption of oilseed rape GT73 is considered safe and no post-market monitoring is required.

EFSA JOURNAL (2022)

Article Food Science & Technology

Assessment of genetically modified soybean MON 87701 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-021)

Ewen Mullins, Jean-Louis Bresson, Tamas Dalmay, Ian Crawford Dewhurst, Michelle M. Epstein, Leslie George Firbank, Philippe Guerche, Jan Hejatko, Francisco Javier Moreno, Hanspeter Naegeli, Fabien Nogue, Nils Rostoks, Jose Juan Sanchez Serrano, Giovanni Savoini, Eve Veromann, Fabio Veronesi, Ana M. Camargo, Tilemachos Goumperis, Aleksandra Lewandowska, Tommaso Raffaello, Franz Streissl

Summary: The Panel on Genetically Modified Organisms of the European Food Safety Authority evaluated the data submitted by Bayer CropScience LP for the renewal application of insect-resistant genetically modified soybean MON 87701. They found no evidence in the renewal application for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment.

EFSA JOURNAL (2022)

Article Food Science & Technology

Animal dietary exposure in the risk assessment of feed derived from genetically modified plants

Ewen Mullins, Jean-Louis Bresson, Tamas Dalmay, Ian Crawford Dewhurst, Michelle M. Epstein, Leslie George Firbank, Philippe Guerche, Jan Hejatko, Francisco Javier Moreno, Hanspeter Naegeli, Fabien Nogue, Nils Rostoks, Jose Juan Sanchez Serrano, Giovanni Savoini, Eve Veromann, Fabio Veronesi, Antonio Fernandez Dumont, Michele Ardizzone

Summary: EFSA conducts risk assessment of genetically modified plants for food and feed uses under Regulation (EU) No 503/2013. Estimating animal dietary exposure to newly expressed proteins is vital for the risk assessment of genetically modified feeds. This statement provides guidance on reporting the information applicants need to provide on animal dietary exposure, including proper feed consumption and concentration data, and also presents an Excel calculator for consistent presentation of exposure estimates.

EFSA JOURNAL (2023)

Article Food Science & Technology

Assessment of genetically modified maize MON 87419 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2017-140)

Ewen Mullins, Jean-Louis Bresson, Tamas Dalmay, Ian Crawford Dewhurst, Michelle M. Epstein, Leslie George Firbank, Philippe Guerche, Jan Hejatko, Francisco Javier Moreno, Hanspeter Naegeli, Fabien Nogue, Nils Rostoks, Jose Juan Sanchez Serrano, Giovanni Savoini, Eve Veromann, Fabio Veronesi, Michele Ardizzone, Giacomo De Sanctis, Silvia Federici, Antonio Fernandez Dumont, Andrea Gennaro, Jose Angel Gomez Ruiz, Tilemachos Goumperis, Anna Lanzoni, Paolo Lenzi, Aleksandra Lewandowska, Ana Martin Camargo, Franco Maria Neri, Nikoletta Papadopoulou, Konstantinos Paraskevopoulos, Tommaso Raffaello

Summary: Genetically modified maize MON 87419 was developed to tolerate certain herbicides, and its safety in terms of food/feed consumption and environmental impact has been assessed. The analyses show that there are no significant differences between MON 87419 and conventional maize, and the levels of arginine and protein do not raise any safety or nutritional concerns. The expressed proteins in MON 87419 do not pose any toxic or allergenic risks. Overall, MON 87419 is considered as safe as its conventional counterpart and non-GM maize varieties.

EFSA JOURNAL (2023)

Article Food Science & Technology

Assessment of genetically modified soybean 40-3-2 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-023)

Ewen Mullins, Jean-Louis Bresson, Tamas Dalmay, Ian Crawford Dewhurst, Michelle M. Epstein, Leslie George Firbank, Philippe Guerche, Jan Hejatko, Francisco Javier Moreno, Hanspeter Naegeli, Fabien Nogue, Nils Rostoks, Jose Juan Sanchez Serrano, Giovanni Savoini, Eve Veromann, Fabio Veronesi, Ana M. Camargo, Tilemachos Goumperis, Paolo Lenzi, Aleksandra Lewandowska, Tommaso Raffaello, Franz Streissl

Summary: During the scientific risk assessment of the renewal application for herbicide-tolerant genetically modified soybean 40-3-2, the GMO Panel concludes that there is no evidence of new hazards, modified exposure, or scientific uncertainties in application EFSA-GMO-RX-023 that would change the conclusions of the original risk assessment.

EFSA JOURNAL (2022)

Article Food Science & Technology

Assessment of genetically modified maize MON 95379 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2020-170)

Ewen Mullins, Jean-Louis Bresson, Tamas Dalmay, Ian Crawford Dewhurst, Michelle M. Epstein, Leslie George Firbank, Philippe Guerche, Jan Hejatko, Francisco Javier Moreno, Hanspeter Naegeli, Fabien Nogue, Nils Rostoks, Jose Juan Sanchez Serrano, Giovanni Savoini, Eve Veromann, Fabio Veronesi, Michele Ardizzone, Ana M. Camargo, Giacomo De Sanctis, Antonio Fernandez, Andrea Gennaro, Jose Angel Gomez Ruiz, Tilemachos Goumperis, Dafni Maria Kagkli, Paolo Lenzi, Franco Maria Neri, Tommaso Raffaello, Franz Streissl

Summary: Genetically modified maize MON 95379 has been developed to fight against certain lepidopteran insect species. The molecular characterisation data and bioinformatic analyses show no safety concerns regarding food/feed safety assessment, agronomic/phenotypic and compositional characteristics, toxicity and allergenicity of the expressed proteins, and overall safety. The consumption of food and feed from MON 95379 does not pose a nutritional concern for humans and animals. In the case of accidental release into the environment, no environmental safety concerns are raised. Maize MON 95379 is considered as safe as its conventional counterpart and non-GM maize varieties in terms of potential effects on human and animal health and the environment.

EFSA JOURNAL (2022)

Article Food Science & Technology

Assessment of genetically modified Maize MON 87429 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2019-161)

Ewen Mullins, Jean-Louis Bresson, Tamas Dalmay, Ian Crawford Dewhurst, Michelle M. Epstein, Leslie George Firbank, Philippe Guerche, Jan Hejatko, Francisco Javier Moreno, Hanspeter Naegeli, Fabien Nogue, Nils Rostoks, Jose Juan Sanchez Serrano, Giovanni Savoini, Eve Veromann, Fabio Veronesi, Michele Ardizzone, Ana Martin Camargo, Giacomo de Sanctis, Silvia Federici, Antonio Fernandez Dumont, Andrea Gennaro, Jose Angel Gomez Ruiz, Tilemachos Goumperis, Dafni Maria Kagkli, Anna Lanzoni, Aleksandra Lewandowska, Paolo Lenzi, Franco Maria Neri, Nikoletta Papadopoulou, Konstantinos Paraskevopoulos, Pietro Piffanelli, Tommaso Raffaello, Franz Streissl

Summary: The genetically modified maize MON 87429 has been found to be as safe as its conventional counterpart and non-GM maize reference varieties in terms of agronomic/phenotypic characteristics, compositional characteristics, and potential effects on human and animal health and the environment. No safety concerns have been identified regarding the toxicity and allergenicity of the proteins expressed in maize MON 87429.

EFSA JOURNAL (2022)

Article Multidisciplinary Sciences

Dynamic interactome of the MHC I peptide loading complex in human dendritic cells

Martina Barends, Nicole Koller, Christian Schoelz, Veronica Duran, Berislav Bosnjak, Jennifer Becker, Marius Doering, Hanna Blees, Reinhold Foerster, Ulrich Kalinke, Robert Tampe

Summary: By studying human dendritic cells, we discovered that additional proteins are recruited to the peptide-loading complex (PLC) during dendritic cell differentiation and maturation, including BAP31, VAPA, and ESYT1. These proteins colocalize with TAP and are in close proximity to the PLC, indicating that the antigen processing machinery is located near ER exit- and membrane contact sites.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Food Science & Technology

Assessment of genetically modified maize MIR162 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-025)

Ewen Mullins, Jean-Louis Bresson, Tamas Dalmay, Ian Crawford Dewhurst, Michelle M. Epstein, Leslie George Firbank, Philippe Guerche, Jan Hejatko, Francisco Javier Moreno, Hanspeter Naegeli, Fabien Nogue, Nils Rostoks, Jose Juan Sanchez Serrano, Giovanni Savoini, Eve Veromann, Fabio Veronesi, Ana Martin Camargo, Tilemachos Goumperis, Dafni Maria Kagkli, Paolo Lenzi, Aleksandra Lewandowska, Tommaso Raffaello, Franz Streissl

Summary: This study assessed the data submitted in the renewal application for the insect-resistant genetically modified maize MIR162. The evaluation found no evidence of new risks, modified exposure, or scientific uncertainties that would alter the conclusions of the original risk assessment for maize MIR162.

EFSA JOURNAL (2022)

Article Allergy

Influence of the environment on ragweed pollen and their sensitizing capacity in a mouse model of allergic lung inflammation

Shu-Hua Liu, Sahar Kazemi, Gerhard Karrer, Anke Bellaire, Wolfram Weckwerth, Jakob Damkjaer, Oskar Hoffmann, Michelle M. Epstein

Summary: Common ragweed pollen concentrations are predicted to increase due to environmental changes, leading to higher rates of allergic sensitization and disease exacerbation. This study found that ragweed pollen collected from different geographical regions induced varying levels of allergic lung disease. However, there was no clear correlation between specific components or structure of the pollen and disease severity.

FRONTIERS IN ALLERGY (2022)

No Data Available